TE
CRNX icon

Tema ETFs’s Crinetics Pharmaceuticals CRNX Stock Holding History

Tema ETFs’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,767
Closed -$408K – 578
2025
Q4 		$408K Sell
8,767
-13,533
-61% -$602K 0.03% 396
2025
Q3 		$929K Sell
22,300
-35,801
-62% -$1.14M 0.08% 272
2025
Q2 		$1.67M Sell
58,101
-706
-1% -$21.8K 0.44% 79
2025
Q1 		$1.97M Buy
58,807
+874
+2% +$32.6K 0.59% 58
2024
Q4 		$2.96M Buy
+57,933
New +$3.24M 1.23% 26

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tema ETFs's CRNX Position: Q1 2026 in Review

Tema ETFs sold out of Crinetics Pharmaceuticals (CRNX) in Q1 2026, closing a stake of 8,767 shares — an estimated $408K sold.

Tema ETFs first reported a position in CRNX in Q4 2024 and held it in 5 quarters. The position peaked at $2.96M in Q4 2024. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • Tema ETFs reported no remaining Crinetics Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Tema ETFs sold 8,767 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $408K.
  • Tema ETFs first reported a position in Crinetics Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Tema ETFs's Crinetics Pharmaceuticals position peaked at $2.96M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Tema ETFs's 13F filing for Q1 2026, filed 15 Apr 2026.